Kif4A mediates resistance to neoadjuvant chemoradiotherapy in patients with advanced colorectal cancer via regulating DNA damage response: Kif4A mediates resistance to neoadjuvant chemoradiotherapy

More and more patients with advanced colorectal cancer (CRC) have benefited from surgical resection or ablation following neoadjuvant chemoradiotherapy (nCRT), but nCRT may be ineffective and have potential risks to some patients. Therefore, it is necessary to discover effective biomarkers for predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Rui, Liu, Shuanghui, Gong, Bojiang, Xie, Wenran, Zhao, Youjuan, Xu, Liang, Zheng, Yi, Jin, Shengnan, Ding, Chunming, Xu, Chang, Dong, Zhixiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828526/
https://www.ncbi.nlm.nih.gov/pubmed/35882623
http://dx.doi.org/10.3724/abbs.2022068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828526/
https://www.ncbi.nlm.nih.gov/pubmed/35882623
http://dx.doi.org/10.3724/abbs.2022068

Ejemplares similares